[1]
Fairall, L. et al. 2025. Real-world effectiveness of Ad26.COV2.S or BNT162b2 booster vaccines against severe COVID-19 in adults who received a primary dose of Ad26.COV2.S in South Africa during the Delta period: A retrospective cohort study using medical scheme data. South African Medical Journal. 115, 7 (Aug. 2025), e2532 . DOI:https://doi.org/10.7196/SAMJ.2025.v115i7.2532.